⌘K

Home/Filings/4/0001144204-18-052159

4//SEC Filing

Chi George 4

Accession 0001144204-18-052159

CIK 0000895051other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 7:20 PM ET

Size

5.4 KB

Accession

0001144204-18-052159

Insider Transaction Report

Form 4

Period: 2018-09-28

CASI Pharmaceuticals, Inc.CASI

Chief Financial Officer

Transactions

Award
Stock Options (Right to Buy)
2018-09-28+400,000→ 400,000 total
Exercise: $4.67Exp: 2028-09-28→ Common Stock (400,000 underlying)

Footnotes (1)

[F1]The stock options vest as follows: 25% on each of the first, second, third and fourth anniversary of the date of grant.

Documents

1 file

4
tv504024_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1

filerCIK 0001753434

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 7:20 PM ET
Size: 5.4 KB

View on SEC.gov